Journal Club- Guideline led COPD Management: Vilanterol or formoterol? Dr. Garima Soni31 March 2025 8:30 AM ISTThis review has been published in the Annals of the National Academy of Medical Sciences published by Scientific Scholar.This comprehensive review...
Indian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA Farhat Nasim19 Nov 2024 6:19 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) experienced a significant 6.8% increase in Total Sales Audit (TSA) over the 12-month period ending...
AstraZeneca gets CDSCO Panel nod to study Budesonide, Glycopyrronium and Formoterol Fumarate Dr. Divya Colin20 Oct 2024 5:45 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Include nebulization methodology, nebulizer types: CDSCO Panel Tells Glenmark pharmaceuticals on Pulmonary FDC Dr. Divya Colin14 Jun 2024 6:00 PM ISTNew Delhi: Citing to include nebulization methodology, type of nebulizer, and interface, the Subject Expert Committee (SEC) functional under the...
Budesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real world study Dr. Shravani Dali7 Jun 2024 8:30 PM ISTBudesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real-world study suggests a study published in the International...
NPPA Revises Ceiling Price of FDC Budesonide Plus Formoterol Inhalation Dr. Divya Colin2 Jun 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Department of...
Show lung deposition of triple drug combination in Inhalation Suspension: CDSCO Panel tells Glenmark on Pulmonary FDC Drug Dr. Divya Colin2 Nov 2023 5:37 PM ISTNew Delhi: In line with the proposal presented by the drug major Glenmark Pharmaceuticals for the bioequivalence (BE) and Phase III clinical trial...
Glenmark Gets CDSCO panel nod for Phase IV CT of COPD drug Dr. Divya Colin22 April 2023 5:45 PM ISTNew Delhi: Pharmaceutical major, Glenmark has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Cipla gets CDSCO Panel nod to manufacture, market COPD drug combination Aerosol for inhalation Susmita Roy23 Nov 2022 6:00 PM ISTNew Delhi: Granting the phase III clinical trial study waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
NPPA panel fixes retail price of Zydus healthcare's Glycopyrrolate, Formoterol,Budesonide metered-dose inhaler Dr. Divya Colin27 March 2022 12:30 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of Glycopyrrolate, Formoterol, and Budesonide...
CDSCO panel asks Cipla to include more Govt sites in Budesonide, Formoterol FDC study Medical Dialogues Team25 Nov 2021 6:02 PM ISTNew Delhi: Recommending to include more government sites, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Lupin gets CDSCO panel nod for phase III trial of Formoterol Fumarate, Budesonide FDC Medical Dialogues Team17 Jun 2021 12:30 PM ISTNew Delhi: Pharmaceutical major, Lupin has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
